NM_024408.4:c.2026+1064G>C
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_024408.4(NOTCH2):c.2026+1064G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0552 in 152,246 control chromosomes in the GnomAD database, including 302 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.055   (  302   hom.,  cov: 32) 
Consequence
 NOTCH2
NM_024408.4 intron
NM_024408.4 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  0.271  
Publications
5 publications found 
Genes affected
 NOTCH2  (HGNC:7882):  (notch receptor 2) This gene encodes a member of the Notch family. Members of this Type 1 transmembrane protein family share structural characteristics including an extracellular domain consisting of multiple epidermal growth factor-like (EGF) repeats, and an intracellular domain consisting of multiple, different domain types. Notch family members play a role in a variety of developmental processes by controlling cell fate decisions. The Notch signaling network is an evolutionarily conserved intercellular signaling pathway which regulates interactions between physically adjacent cells. In Drosophilia, notch interaction with its cell-bound ligands (delta, serrate) establishes an intercellular signaling pathway that plays a key role in development. Homologues of the notch-ligands have also been identified in human, but precise interactions between these ligands and the human notch homologues remain to be determined. This protein is cleaved in the trans-Golgi network, and presented on the cell surface as a heterodimer. This protein functions as a receptor for membrane bound ligands, and may play a role in vascular, renal and hepatic development. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2011] 
NOTCH2 Gene-Disease associations (from GenCC):
- acroosteolysis dominant typeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae)
- Alagille syndrome due to a NOTCH2 point mutationInheritance: AD Classification: STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- Alagille syndromeInheritance: AD Classification: MODERATE Submitted by: Illumina
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83). 
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.158  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| NOTCH2 | ENST00000256646.7 | c.2026+1064G>C | intron_variant | Intron 12 of 33 | 1 | NM_024408.4 | ENSP00000256646.2 | |||
| NOTCH2 | ENST00000479412.2 | n.2164+1064G>C | intron_variant | Intron 11 of 13 | 1 | |||||
| NOTCH2 | ENST00000640021.1 | n.*1150+1064G>C | intron_variant | Intron 9 of 11 | 5 | ENSP00000492223.1 | 
Frequencies
GnomAD3 genomes  0.0552  AC: 8398AN: 152128Hom.:  301  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
8398
AN: 
152128
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome  0.0552  AC: 8406AN: 152246Hom.:  302  Cov.: 32 AF XY:  0.0571  AC XY: 4252AN XY: 74426 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
8406
AN: 
152246
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
4252
AN XY: 
74426
show subpopulations 
African (AFR) 
 AF: 
AC: 
1893
AN: 
41530
American (AMR) 
 AF: 
AC: 
756
AN: 
15300
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
236
AN: 
3466
East Asian (EAS) 
 AF: 
AC: 
123
AN: 
5182
South Asian (SAS) 
 AF: 
AC: 
809
AN: 
4824
European-Finnish (FIN) 
 AF: 
AC: 
562
AN: 
10612
Middle Eastern (MID) 
 AF: 
AC: 
18
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
3812
AN: 
68012
Other (OTH) 
 AF: 
AC: 
143
AN: 
2114
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.502 
Heterozygous variant carriers
 0 
 407 
 815 
 1222 
 1630 
 2037 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 102 
 204 
 306 
 408 
 510 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
397
AN: 
3478
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.